Byung-Sik Cho

2 clinical trials · Sponsor

Record	Firm	Date
Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity (NCT06756061)	Byung-Sik Cho	2025-01-15

Every clearance here is in the API, with alerts when new ones post.